• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Regulatory press release

Nykode Therapeutics ASA - Notice of Extraordinary General Meeting

Nykode Therapeutics
Oslo, Norway, December 18, 2025 - The Board of Directors of Nykode Therapeutics
ASA (OSE: NYKD) hereby calls for an Extraordinary General Meeting (EGM) to be
held at meeting room VIA - Building G, Floor 0 in Gaustadalléen 21, Oslo, Norway
at 10:00 CET on January 21, 2026.

The purpose of the meeting is to elect a new Chair of the Board and additional
Board members, including the current interim Chair of the Board.

The notice of the EGM is attached. All documents regarding the EGM will also be
made available at the Company's website:
https://nykode.com/investors/shareholder-meetings/

For further information, please see the Company's website or contact the Company
at IR@nykode.com


This information is subject to the disclosure requirements pursuant to sections
5-12 of the Norwegian Securities Trading Act.